Matches in Wikidata for { <http://www.wikidata.org/entity/Q98155171> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q98155171 description "article scientifique publié en 2020" @default.
- Q98155171 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q98155171 description "scientific article published on 25 July 2020" @default.
- Q98155171 description "wetenschappelijk artikel" @default.
- Q98155171 description "наукова стаття, опублікована 25 липня 2020" @default.
- Q98155171 name "Efficacy of a Combination of HBV RNA and HBeAg in Predicting HBeAg Seroconversion in Patients Treated with Entecavir for 144 Weeks" @default.
- Q98155171 name "Efficacy of a Combination of HBV RNA and HBeAg in Predicting HBeAg Seroconversion in Patients Treated with Entecavir for 144 Weeks" @default.
- Q98155171 type Item @default.
- Q98155171 label "Efficacy of a Combination of HBV RNA and HBeAg in Predicting HBeAg Seroconversion in Patients Treated with Entecavir for 144 Weeks" @default.
- Q98155171 label "Efficacy of a Combination of HBV RNA and HBeAg in Predicting HBeAg Seroconversion in Patients Treated with Entecavir for 144 Weeks" @default.
- Q98155171 prefLabel "Efficacy of a Combination of HBV RNA and HBeAg in Predicting HBeAg Seroconversion in Patients Treated with Entecavir for 144 Weeks" @default.
- Q98155171 prefLabel "Efficacy of a Combination of HBV RNA and HBeAg in Predicting HBeAg Seroconversion in Patients Treated with Entecavir for 144 Weeks" @default.
- Q98155171 P1433 Q98155171-C1BF3DE8-65EC-4415-8103-166DF57A461B @default.
- Q98155171 P1476 Q98155171-9ED50AEA-BB3D-4742-8A8E-6D02D1473BC7 @default.
- Q98155171 P2093 Q98155171-0275D6A4-E710-4BC4-9EF7-E6CC9492662A @default.
- Q98155171 P2093 Q98155171-064B0077-F2FB-41CA-AB6E-74CB0A2E1812 @default.
- Q98155171 P2093 Q98155171-14010353-DEDE-494F-A775-50C41087B4CF @default.
- Q98155171 P2093 Q98155171-1AEF41CE-A03F-4175-96EE-F4370886AB7F @default.
- Q98155171 P2093 Q98155171-1BE98F58-A348-4792-8EE9-7969814C9011 @default.
- Q98155171 P2093 Q98155171-2FE9AD17-4C92-4B6C-9985-1FD1D6003361 @default.
- Q98155171 P2093 Q98155171-360F51F9-BA77-446C-A206-ADF0E85DACB0 @default.
- Q98155171 P2093 Q98155171-42902B4E-5D19-4499-B45E-3A5D2A569E33 @default.
- Q98155171 P2093 Q98155171-50F1FC27-8FD9-41CF-BD60-2585CB044762 @default.
- Q98155171 P2093 Q98155171-66959EF4-F15E-4E29-890A-F11C94930557 @default.
- Q98155171 P2093 Q98155171-6FDD8351-F4C0-4C90-AC54-18324B91D44F @default.
- Q98155171 P2093 Q98155171-70CD8032-8F77-442E-9338-0DBD456ACD8E @default.
- Q98155171 P2093 Q98155171-71C193E5-B381-4849-8A37-CFC39312549A @default.
- Q98155171 P2093 Q98155171-8222C8BB-E552-48DE-85D5-F65F584E6DB3 @default.
- Q98155171 P2093 Q98155171-8F77491C-1AFE-48B8-9288-7A4D193990FD @default.
- Q98155171 P2093 Q98155171-96082667-0146-4346-AF05-3E62CB48E0C6 @default.
- Q98155171 P2093 Q98155171-97F50B14-7434-4393-9FCB-3ACC2EDFA790 @default.
- Q98155171 P2093 Q98155171-9E37836B-79C2-42DD-B28B-90217F96823B @default.
- Q98155171 P2093 Q98155171-9E8A2AD9-C02D-4E70-9F08-FDA45BC6C913 @default.
- Q98155171 P2093 Q98155171-B8A5CBC1-6C70-43B4-ACBA-8C39A2B19982 @default.
- Q98155171 P2093 Q98155171-B904ED27-D30C-40A0-828D-212CB4030BBA @default.
- Q98155171 P2093 Q98155171-C111AD3D-0F5C-49C8-9544-230A8E5E7F82 @default.
- Q98155171 P2093 Q98155171-DB433B11-708F-4CF4-8352-801055E5CD99 @default.
- Q98155171 P2093 Q98155171-F8CC2AE7-FFFA-456E-9A41-9DE03EF48B98 @default.
- Q98155171 P2093 Q98155171-FD252FBB-B3AF-4560-87A5-D0D704E17288 @default.
- Q98155171 P31 Q98155171-7839CB7C-2A81-485F-81F7-BE6938F0B043 @default.
- Q98155171 P356 Q98155171-23B278A8-23C2-4780-AFB0-782214AA62AD @default.
- Q98155171 P577 Q98155171-F4FB260D-2505-4CA2-BAE2-130525C5AEE5 @default.
- Q98155171 P698 Q98155171-5C8AB672-DF2C-46D1-9465-8C5727E4D1F5 @default.
- Q98155171 P921 Q98155171-8E2A62CF-20E1-42BA-BEE8-73F630DD3D81 @default.
- Q98155171 P356 J.IJID.2020.07.031 @default.
- Q98155171 P698 32721532 @default.
- Q98155171 P1433 Q15262334 @default.
- Q98155171 P1476 "Efficacy of a Combination of HBV RNA and HBeAg in Predicting HBeAg Seroconversion in Patients Treated with Entecavir for 144 Weeks" @default.
- Q98155171 P2093 "Anlin Ma" @default.
- Q98155171 P2093 "Bin Xu" @default.
- Q98155171 P2093 "Fengmin Lu" @default.
- Q98155171 P2093 "Hongqin Xu" @default.
- Q98155171 P2093 "Jia Li" @default.
- Q98155171 P2093 "Jia Shang" @default.
- Q98155171 P2093 "Junqi Niu" @default.
- Q98155171 P2093 "Lei Yu" @default.
- Q98155171 P2093 "Longgen Liu" @default.
- Q98155171 P2093 "Lunli Zhang" @default.
- Q98155171 P2093 "Mingxiang Zhang" @default.
- Q98155171 P2093 "Qiaoxia Tong" @default.
- Q98155171 P2093 "Qinglong Jin" @default.
- Q98155171 P2093 "Ruihong Wu" @default.
- Q98155171 P2093 "Shuangsuo Dang" @default.
- Q98155171 P2093 "Shuqin Zhang" @default.
- Q98155171 P2093 "Xiaobo Li" @default.
- Q98155171 P2093 "Xiaomei Wang" @default.
- Q98155171 P2093 "Xiumei Chi" @default.
- Q98155171 P2093 "Xiuzhu Gao" @default.
- Q98155171 P2093 "Yongfang Jiang" @default.
- Q98155171 P2093 "Youwen Tan" @default.
- Q98155171 P2093 "Yuping Chen" @default.
- Q98155171 P2093 "Zhenjing Jin" @default.
- Q98155171 P2093 "Zhongfeng Wang" @default.
- Q98155171 P31 Q13442814 @default.
- Q98155171 P356 "10.1016/J.IJID.2020.07.031" @default.
- Q98155171 P577 "2020-07-25T00:00:00Z" @default.
- Q98155171 P698 "32721532" @default.
- Q98155171 P921 Q418586 @default.